Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group

L. C. Clark, G. F. Combs Jr, B. W. Turnbull, E. H. Slate, D. K. Chalker, J. Chow, L. S. Davis, R. A. Glover, G. F. Graham, E. G. Gross, A. Krongrad, J. L. Lesher Jr, H. K. Park, B. B. Sanders Jr, C. L. Smith and J. R. Taylor
Arizona Cancer Center, College of Medicine, University of Arizona, Tucson, USA.

OBJECTIVE: To determine whether a nutritional supplement of selenium will decrease the incidence of cancer. DESIGN: A multicenter, double-blind, randomized, placebo-controlled cancer prevention trial. SETTING: Seven dermatology clinics in the eastern United States. PATIENTS: A total of 1312 patients (mean age, 63 years; range, 18-80 years) with a history of basal cell or squamous cell carcinomas of the skin were randomized from 1983 through 1991. Patients were treated for a mean (SD) of 4.5 (2.8) years and had a total follow-up of 6.4 (2.0) years. INTERVENTIONS: Oral administration of 200 microg of selenium per day or placebo. MAIN OUTCOME MEASURES: The primary end points for the trial were the incidences of basal and squamous cell carcinomas of the skin. The secondary end points, established in 1990, were all-cause mortality and total cancer mortality, total cancer incidence, and the incidences of lung, prostate, and colorectal cancers. RESULTS: After a total follow-up of 8271 person-years, selenium treatment did not significantly affect the incidence of basal cell or squamous cell skin cancer. There were 377 new cases of basal cell skin cancer among patients in the selenium group and 350 cases among the control group (relative risk [RR], 1.10; 95% confidence interval [CI], 0.95-1.28), and 218 new squamous cell skin cancers in the selenium group and 190 cases among the controls (RR, 1.14; 95% CI, 0.93-1.39). Analysis of secondary end points revealed that, compared with controls, patients treated with selenium had a nonsignificant reduction in all-cause mortality (108 deaths in the selenium group and 129 deaths in the control group [RR; 0.83; 95% CI, 0.63-1.08]) and significant reductions in total cancer mortality (29 deaths in the selenium treatment group and 57 deaths in controls [RR, 0.50; 95% CI, 0.31-0.80]), total cancer incidence (77 cancers in the selenium group and 119 in controls [RR, 0.63; 95% CI, 0.47-0.85]), and incidences of lung, colorectal, and prostate cancers. Primarily because of the apparent reductions in total cancer mortality and total cancer incidence in the selenium group, the blinded phase of the trial was stopped early. No cases of selenium toxicity occurred. CONCLUSIONS: Selenium treatment did not protect against development of basal or squamous cell carcinomas of the skin. However, results from secondary end-point analyses support the hypothesis that supplemental selenium may reduce the incidence of, and mortality from, carcinomas of several sites. These effects of selenium require confirmation in an independent trial of appropriate design before new public health recommendations regarding selenium supplementation can be made

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells
Li et al.
Molecular Cancer Therapeutics 2008;7:3056-3063.
ABSTRACT | FULL TEXT  

Chemopreventive Doses of Methylselenocysteine Alter Circadian Rhythm in Rat Mammary Tissue
Zhang and Zarbl
Cancer Prevention Research 2008;1:119-127.
ABSTRACT | FULL TEXT  

Suppression of Colorectal Oncogenesis by Selenium-Enriched Milk Proteins: Apoptosis and K-ras Mutations
Hu et al.
Cancer Res. 2008;68:4936-4944.
ABSTRACT | FULL TEXT  

Tumor Vascular Maturation and Improved Drug Delivery Induced by Methylselenocysteine Leads to Therapeutic Synergy with Anticancer Drugs
Bhattacharya et al.
Clin. Cancer Res. 2008;14:3926-3932.
ABSTRACT | FULL TEXT  

Variation in the Selenoenzyme Genes and Risk of Advanced Distal Colorectal Adenoma
Peters et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1144-1154.
ABSTRACT | FULL TEXT  

Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite
Li et al.
Carcinogenesis 2008;29:1005-1012.
ABSTRACT | FULL TEXT  

Interaction of Glutathione and Sodium Selenite In vitro Investigated by Electrospray Ionization Tandem Mass Spectrometry
Cui et al.
J Biochem 2008;143:685-693.
ABSTRACT | FULL TEXT  

The Role of Selenium in Chronic Disease
Boosalis
Nutr Clin Pract 2008;23:152-160.
ABSTRACT | FULL TEXT  

Effects of level and source of dietary selenium on maternal and fetal body weight, visceral organ mass, cellularity estimates, and jejunal vascularity in pregnant ewe lambs
Neville et al.
J ANIM SCI 2008;86:890-901.
ABSTRACT | FULL TEXT  

Effect of Dietary Selenium on the Promotion of Hepatocarcinogenesis by 3,3', 4,4'-Tetrachlorobiphenyl and 2,2', 4,4', 5,5'-Hexachlorobiphenyl
Stemm et al.
Exp. Biol. Med. 2008;233:366-376.
ABSTRACT | FULL TEXT  

A dynamic website for a government/industry-funded project exploring biofortification of wheat with selenium
Adams
Bioscience Horizons 2008;1:75-84.
ABSTRACT | FULL TEXT  

Serum Selenium Levels and All-Cause, Cancer, and Cardiovascular Mortality Among US Adults
Bleys et al.
Arch Intern Med 2008;168:404-410.
ABSTRACT | FULL TEXT  

Kruppel-Like Factor 4 Is a Novel Mediator of Selenium in Growth Inhibition
Liu et al.
Mol Cancer Res 2008;6:306-313.
ABSTRACT | FULL TEXT  

Animal Models in Nutrition Research
Baker
J. Nutr. 2008;138:391-396.
ABSTRACT | FULL TEXT  

Selenium status alters tumour differentiation but not incidence or latency of pancreatic adenocarcinomas in Ela-TGF-{alpha} p53+/ mice
Aichler et al.
Carcinogenesis 2007;28:2002-2007.
ABSTRACT | FULL TEXT  

Antioxidant Supplementation Increases the Risk of Skin Cancers in Women but Not in Men
Hercberg et al.
J. Nutr. 2007;137:2098-2105.
ABSTRACT | FULL TEXT  

Effects of Long-Term Selenium Supplementation on the Incidence of Type 2 Diabetes: A Randomized Trial
Stranges et al.
ANN INTERN MED 2007;147:217-223.
ABSTRACT | FULL TEXT  

Racial Differences in Serum Selenium Concentration: Analysis of US Population Data from the Third National Health and Nutrition Examination Survey
Vogt et al.
Am J Epidemiol 2007;166:280-288.
ABSTRACT | FULL TEXT  

Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-{kappa}B activation
Park et al.
Carcinogenesis 2007;28:837-847.
ABSTRACT | FULL TEXT  

Extracellular Production of Hydrogen Selenide Accounts for Thiol-assisted Toxicity of Selenite against Saccharomyces cerevisiae
Tarze et al.
J. Biol. Chem. 2007;282:8759-8767.
ABSTRACT | FULL TEXT  

Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention: Systematic Review and Meta-analysis
Bjelakovic et al.
JAMA 2007;297:842-857.
ABSTRACT | FULL TEXT  

Suppression of Human Immunodeficiency Virus Type 1 Viral Load With Selenium Supplementation: A Randomized Controlled Trial
Hurwitz et al.
Arch Intern Med 2007;167:148-154.
ABSTRACT | FULL TEXT  

National Institutes of Health State-of-the-Science Conference Statement: Multivitamin/Mineral Supplements and Chronic Disease Prevention
NIH State-of-the Science Panel
Am. J. Clin. Nutr. 2007;85:257S-264S.
FULL TEXT  

Clinical trials and observational studies to assess the chronic disease benefits and risks of multivitamin-multimineral supplements
Prentice
Am. J. Clin. Nutr. 2007;85:308S-313S.
ABSTRACT | FULL TEXT  

The Biological Revolution: Understanding the Impact of SNPs on Diet-Cancer Interrelationships
Mathers and Hesketh
J. Nutr. 2007;137:253S-258S.
ABSTRACT | FULL TEXT  

Poster Abstracts
J. Nutr. 2007;137:278S-295S.
FULL TEXT  

Apoptosis induced by selenomethionine and methioninase is superoxide mediated and p53 dependent in human prostate cancer cells
Zhao et al.
Molecular Cancer Therapeutics 2006;5:3275-3284.
ABSTRACT | FULL TEXT  

Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices
Doyle et al.
CA Cancer J Clin 2006;56:323-353.
ABSTRACT | FULL TEXT  

Chemoprevention of Second Cancers
Mayne and Cartmel
Cancer Epidemiol. Biomarkers Prev. 2006;15:2033-2037.
ABSTRACT | FULL TEXT  

Selenium and coronary heart disease: a meta-analysis.
Flores-Mateo et al.
Am. J. Clin. Nutr. 2006;84:762-773.
ABSTRACT | FULL TEXT  

Brassica vegetable consumption reduces urinary F2-isoprostane levels independent of micronutrient intake
Fowke et al.
Carcinogenesis 2006;27:2096-2102.
ABSTRACT | FULL TEXT  

National Institutes of Health State-of-the-Science Conference Statement: Multivitamin/Mineral Supplements and Chronic Disease Prevention
NIH State-of-the-Science Panel*
ANN INTERN MED 2006;145:364-371.
FULL TEXT  

Enhancement of mammary carcinogenesis in two rodent models by silymarin dietary supplements
Malewicz et al.
Carcinogenesis 2006;27:1739-1747.
ABSTRACT | FULL TEXT  

Micronutrients in health and disease.
Shenkin
Postgrad. Med. J. 2006;82:559-567.
ABSTRACT | FULL TEXT  

Design and Progress of a Trial of Selenium to Prevent Prostate Cancer among Men with High-Grade Prostatic Intraepithelial Neoplasia.
Marshall et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:1479-1484.
ABSTRACT | FULL TEXT  

Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action.
Husbeck et al.
Molecular Cancer Therapeutics 2006;5:2078-2085.
ABSTRACT | FULL TEXT  

(Nutritional) chemoprevention of cancer: what's up?
Baron
JNCI J Natl Cancer Inst 2006;98:945-946.
FULL TEXT  

Nutritional interventions and outcome in patients with cancer or preinvasive lesions: systematic review.
Davies et al.
JNCI J Natl Cancer Inst 2006;98:961-973.
ABSTRACT | FULL TEXT  

Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway.
Hu et al.
Molecular Cancer Therapeutics 2006;5:1873-1882.
ABSTRACT | FULL TEXT  

Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer
El-Bayoumy et al.
Carcinogenesis 2006;27:1369-1376.
ABSTRACT | FULL TEXT  

Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer--A Plan to Move Forward
Kelloff et al.
Clin. Cancer Res. 2006;12:3661-3697.
ABSTRACT | FULL TEXT  

Lessons Learned From International Comparative Crosscultural Studies on Dementia.
Hendrie
AJGP 2006;14:480-488.
ABSTRACT | FULL TEXT  

Toward a core nutraceutical program for cancer management.
McCarty and Block
Integr Cancer Ther 2006;5:150-171.
ABSTRACT  

The Selenium Metabolite Methylselenol Inhibits the Migration and Invasion Potential of HT1080 Tumor Cells
Zeng et al.
J. Nutr. 2006;136:1528-1532.
ABSTRACT | FULL TEXT  

Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model
Diwadkar-Navsariwala et al.
Proc. Natl. Acad. Sci. USA 2006;103:8179-8184.
ABSTRACT | FULL TEXT  

The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours
Last et al.
Ann Oncol 2006;17:773-779.
ABSTRACT | FULL TEXT  

Both Selenoproteins and Low Molecular Weight Selenocompounds Reduce Colon Cancer Risk in Mice with Genetically Impaired Selenoprotein Expression
Irons et al.
J. Nutr. 2006;136:1311-1317.
ABSTRACT | FULL TEXT  

Effects of Selenium Supplementation on Cardiovascular Disease Incidence and Mortality: Secondary Analyses in a Randomized Clinical Trial
Stranges et al.
Am J Epidemiol 2006;163:694-699.
ABSTRACT | FULL TEXT  

Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial.
Burk et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:804-810.
ABSTRACT | FULL TEXT  

Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer.
Chun et al.
Molecular Cancer Therapeutics 2006;5:913-918.
ABSTRACT | FULL TEXT  

Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study.
Sabichi et al.
Clin. Cancer Res. 2006;12:2178-2184.
ABSTRACT | FULL TEXT  

Selenium, apoptosis, and colorectal adenomas.
Connelly-Frost et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:486-493.
ABSTRACT | FULL TEXT  

Cancer Chemoprevention by Garlic and Garlic-Containing Sulfur and Selenium Compounds
El-Bayoumy et al.
J. Nutr. 2006;136:864S-869S.
ABSTRACT | FULL TEXT  

Hydroponic Cultivation Offers A Practical Means of Producing Selenium-Enriched Garlic
Tsuneyoshi et al.
J. Nutr. 2006;136:870S-872S.
ABSTRACT | FULL TEXT  

Expression of p53 Enhances Selenite-Induced Superoxide Production and Apoptosis in Human Prostate Cancer Cells
Zhao et al.
Cancer Res. 2006;66:2296-2304.
ABSTRACT | FULL TEXT  

A Phase I and Pharmacokinetic Study of Fixed-Dose Selenomethionine and Irinotecan in Solid Tumors
Fakih et al.
Clin. Cancer Res. 2006;12:1237-1244.
ABSTRACT | FULL TEXT  

NMR Structures of the Selenoproteins Sep15 and SelM Reveal Redox Activity of a New Thioredoxin-like Family
Ferguson et al.
J. Biol. Chem. 2006;281:3536-3543.
ABSTRACT | FULL TEXT  

Dietary Selenium Intake and Genetic Polymorphisms of the GSTP1 and p53 Genes on the Risk of Esophageal Squamous Cell Carcinoma.
Cai et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:294-300.
ABSTRACT | FULL TEXT  

High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program.
Peters et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:315-320.
ABSTRACT | FULL TEXT  

Toxicology of Micronutrients: Adverse Effects and Uncertainty
Renwick
J. Nutr. 2006;136:493S-501S.
ABSTRACT | FULL TEXT  

Selenium, the Thyroid, and the Endocrine System
Kohrle et al.
Endocr. Rev. 2005;26:944-984.
ABSTRACT | FULL TEXT  

Allelic Loss of the Gene for the GPX1 Selenium-Containing Protein Is a Common Event in Cancer
Hu et al.
J. Nutr. 2005;135:3021S-3024S.
ABSTRACT | FULL TEXT  

A Novel Cysteine-rich Domain of Sep15 Mediates the Interaction with UDP-glucose:Glycoprotein Glucosyltransferase
Labunskyy et al.
J. Biol. Chem. 2005;280:37839-37845.
ABSTRACT | FULL TEXT  

Additional Information
JAMA 2005;294:E1-E3.
FULL TEXT  

Selenium and Mortality in the Elderly: Results from the EVA Study
Akbaraly et al.
Clin. Chem. 2005;51:2117-2123.
ABSTRACT | FULL TEXT  

Selenium disrupts estrogen receptor {alpha} signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells
Shah et al.
Molecular Cancer Therapeutics 2005;4:1239-1249.
ABSTRACT | FULL TEXT  

PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells
Hu et al.
Carcinogenesis 2005;26:1374-1381.
ABSTRACT | FULL TEXT  

Role of Dietary Factors in the Development of Basal Cell Cancer and Squamous Cell Cancer of the Skin
McNaughton et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:1596-1607.
ABSTRACT | FULL TEXT  

Changes in Serum Proteomic Patterns by Presurgical {alpha}-Tocopherol and L-Selenomethionine Supplementation in Prostate Cancer
Kim et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:1697-1702.
ABSTRACT | FULL TEXT  

Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers
Dong et al.
Molecular Cancer Therapeutics 2005;4:1047-1055.
ABSTRACT | FULL TEXT  

Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model
Waters et al.
Carcinogenesis 2005;26:1256-1262.
ABSTRACT | FULL TEXT  

Proposed Criteria for Assessing the Efficacy of Cancer Reduction by Plant Foods Enriched in Carotenoids, Glucosinolates, Polyphenols and Selenocompounds
FINLEY
ANN BOT (LOND) 2005;95:1075-1096.
ABSTRACT | FULL TEXT  

Placental angiogenesis in sheep models of compromised pregnancy
Reynolds et al.
J. Physiol. 2005;565:43-58.
ABSTRACT | FULL TEXT  

Advances in the Biology of Lung Cancer Chemoprevention
Hirsch and Lippman
JCO 2005;23:3186-3197.
ABSTRACT | FULL TEXT  

Increased Rates of Chromosome Breakage in BRCA1 Carriers Are Normalized by Oral Selenium Supplementation
Kowalska et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:1302-1306.
ABSTRACT | FULL TEXT  

Selenium Enrichment of Broccoli: Interactions between Selenium and Secondary Plant Compounds
Finley et al.
J. Nutr. 2005;135:1236-1238.
ABSTRACT | FULL TEXT  

Molecular and Biochemical Characterization of the Selenocysteine Se-Methyltransferase Gene and Se-Methylselenocysteine Synthesis in Broccoli
Lyi et al.
Plant Physiol. 2005;138:409-420.
ABSTRACT | FULL TEXT  

Selenium Disrupts Estrogen Signaling by Altering Estrogen Receptor Expression and Ligand Binding in Human Breast Cancer Cells
Lee et al.
Cancer Res. 2005;65:3487-3492.
ABSTRACT | FULL TEXT  

Epithelium-Specific Glutathione Peroxidase, Gpx2, Is Involved in the Prevention of Intestinal Inflammation in Selenium-Deficient Mice
Esworthy et al.
J. Nutr. 2005;135:740-745.
ABSTRACT | FULL TEXT  

Methylseleninic Acid Potentiates Apoptosis Induced by Chemotherapeutic Drugs in Androgen-Independent Prostate Cancer Cells
Hu et al.
Clin. Cancer Res. 2005;11:2379-2388.
ABSTRACT | FULL TEXT  

Naturopathic Approach
Yarnell and Philhower
Integr Cancer Ther 2005;4:53-58.
 

Effect of the Synthetic Retinoid Fenretinide on Circulating Free Prostate-Specific Antigen, Insulin-Like Growth Factor-I, and Insulin-Like Growth Factor Binding Protein-3 Levels in Men with Superficial Bladder Cancer
Serrano et al.
Clin. Cancer Res. 2005;11:2083-2088.
ABSTRACT | FULL TEXT  

Current Evidence and Research Needs to Support a Health Claim for Selenium and Cancer Prevention
Combs
J. Nutr. 2005;135:343-347.
ABSTRACT | FULL TEXT  

The Level of Evidence for Permitting a Qualified Health Claim: FDA's Review of the Evidence for Selenium and Cancer and Vitamin E and Heart Disease
Trumbo
J. Nutr. 2005;135:354-356.
ABSTRACT | FULL TEXT  

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Lippman et al.
JNCI J Natl Cancer Inst 2005;97:94-102.
ABSTRACT | FULL TEXT  

Nutritional Interventions in Cancer Prevention
Taylor and Greenwald
JCO 2005;23:333-345.
ABSTRACT | FULL TEXT  

Colorectal Cancer Prevention
Hawk and Levin
JCO 2005;23:378-391.
ABSTRACT | FULL TEXT  

Selenomethionine induces sustained ERK phosphorylation leading to cell-cycle arrest in human colon cancer cells
Goulet et al.
Carcinogenesis 2005;26:109-117.
ABSTRACT | FULL TEXT  

Dietary Antioxidants and Human Cancer
Borek
Integr Cancer Ther 2004;3:333-341.
ABSTRACT  

Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and {beta}-catenin pathways in colon cancer cells
Narayanan et al.
Carcinogenesis 2004;25:2443-2449.
ABSTRACT | FULL TEXT  

Selenium Metabolites in Urine: A Critical Overview of Past Work and Current Status
Francesconi and Pannier
Clin. Chem. 2004;50:2240-2253.
ABSTRACT | FULL TEXT  

Selenium and Colorectal Adenoma: Results of a Pooled Analysis
Jacobs et al.
JNCI J Natl Cancer Inst 2004;96:1669-1675.
ABSTRACT | FULL TEXT  

The Link between Selenium and Chemoprevention: A Case for Selenoproteins
Diwadkar-Navsariwala and Diamond
J. Nutr. 2004;134:2899-2902.
ABSTRACT | FULL TEXT  

Molecular Targets for Bioactive Food Components
Milner
J. Nutr. 2004;134:2492S-2498S.
ABSTRACT | FULL TEXT  

Antioxidants Block Prostate Cancer in Lady Transgenic Mice
Venkateswaran et al.
Cancer Res. 2004;64:5891-5896.
ABSTRACT | FULL TEXT  

Hormones and Supplements: Do They Work?: Micronutrient Supplementation in Later Life: Limited Evidence for Benefit
Dangour et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2004;59:B659-B673.
ABSTRACT | FULL TEXT  

Enhanced 7-Ethyl-10-hydroxycamptothecin (SN-38) Lethality by Methylselenocysteine Is Associated with Chk2 Phosphorylation at Threonine-68 and Down-Regulation of Cdc6 Expression
Yin et al.
Mol. Pharmacol. 2004;66:153-160.
ABSTRACT | FULL TEXT